Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 3Phase 1/2 2

Status

Not yet recruiting 3Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 6Other solid neoplasm 1

Conditions

Breast Neoplasms 2760Carcinoma, Non-Small-Cell Lung 2260Prostatic Neoplasms 1425Colorectal Neoplasms 1290Neoplasms 1258Multiple Myeloma 1084Lung Neoplasms 1048Neoplasm Metastasis 994Leukemia, Myeloid, Acute 984Lymphoma 900Melanoma 862Pancreatic Neoplasms 818Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 753Recurrence 750Leukemia 733Lymphoma, Non-Hodgkin 684Leukemia, Lymphocytic, Chronic, B-Cell 665Lymphoma, Large B-Cell, Diffuse 616Squamous Cell Carcinoma of Head and Neck 615Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 596Brain Neoplasms 592Carcinoma, Renal Cell 586Glioblastoma 572Rectal Neoplasms 563Myelodysplastic Syndromes 522Sarcoma 521Lymphoma, Follicular 516

Interventions

tislelizumab 1atezolizumab 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × SCLC, Extensive Stage × Clear all
NCT06812260 2026-05-20

A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC

Shanghai Henlius Biotech

Phase 2 Active not recruiting
26 enrolled
Thoracic

SCLC, Extensive Stage

NCT07321574 2026-01-07

ABP1011T-03

Shanghai AB PharmaTech Ltd.

Phase 2 Recruiting
110 enrolled
Other solid neoplasmThoracic

SCLC, Extensive Stage

NCT04221529 2025-09-08

SPACE

AIO-Studien-gGmbH

Phase 2 Completed
70 enrolled
Thoracic

SCLC, Extensive Stage

NCT06793228 2025-01-27

Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

Henan Cancer Hospital

Phase 2 Not yet recruiting
250 enrolled
Thoracic

SCLC, Extensive Stage

NCT06768307 2025-01-10

Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Peking University Cancer Hospital & Institute

Phase 2 Not yet recruiting
60 enrolled
Thoracic

SCLC, Extensive Stage

NCT06620796 2024-10-01

A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Not yet recruiting
70 enrolled
Thoracic

SCLC, Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡